Long-term clinical outcomes of carvedilol versus nebivolol in patients with ST-segment elevation myocardial infarction treated with second-generation drug-eluting stents: insights from a Korean nationwide multicenter prospective registry.
- DOI
- 10.3389/fcvm.2026.1865226
- Published
- 2026
- Container
- Frontiers in cardiovascular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fcvm.2026.1865226,
title = {Long-term clinical outcomes of carvedilol versus nebivolol in patients with ST-segment elevation myocardial infarction treated with second-generation drug-eluting stents: insights from a Korean nationwide multicenter prospective registry.},
author = {Ahn J and Yu HY and Rha SW and Choi SY and Byun JK and Park S and Choi CU and Ahn Y and Jin D and Choi BG},
year = {2026},
journal = {Frontiers in cardiovascular medicine},
doi = {10.3389/fcvm.2026.1865226},
url = {https://doi.org/10.3389/fcvm.2026.1865226}
}RIS
TY - JOUR TI - Long-term clinical outcomes of carvedilol versus nebivolol in patients with ST-segment elevation myocardial infarction treated with second-generation drug-eluting stents: insights from a Korean nationwide multicenter prospective registry. AU - Ahn J AU - Yu HY AU - Rha SW AU - Choi SY AU - Byun JK AU - Park S AU - Choi CU AU - Ahn Y AU - Jin D AU - Choi BG PY - 2026 JO - Frontiers in cardiovascular medicine DO - 10.3389/fcvm.2026.1865226 UR - https://doi.org/10.3389/fcvm.2026.1865226 ER -
APA
J, A., HY, Y., SW, R., SY, C., JK, B., S, P., CU, C., Y, A., D, J., & BG, C. (2026). Long-term clinical outcomes of carvedilol versus nebivolol in patients with ST-segment elevation myocardial infarction treated with second-generation drug-eluting stents: insights from a Korean nationwide multicenter prospective registry.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1865226
Source records
- pubmed · retrieved 2026-09-27T13:08:12.189Z
- europe-pmc · retrieved 2026-09-27T13:08:12.200Z
- doaj · retrieved 2026-09-27T13:08:12.189Z